Medifast reported Q2 GAAP EPS of -$0.28, beating estimates by $0.37, and revenue of $76.4M, $3.7M above expectations.
Medifast Inc. shares surged over 32% after the company posted stronger-than-expected second-quarter earnings. The health and wellness firm reported a GAAP EPS loss of $0.28, outperforming Wall Street estimates by $0.37. Revenue reached $76.4M, exceeding market expectations by $3.7M.
Analysts had anticipated weaker results following prior quarter declines. The beat signals potential traction in the company’s turnaround efforts, contrasting with earlier struggles in revenue growth and profitability.
The earnings surprise drove a sharp rally in Medifast stock, reflecting investor optimism about the company’s recovery trajectory.